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Retroviral gp7O antigen In spontaneous mesangial glomerulonephritis
of ddY mice. We examined whether the retroviral envelope antigen,
gp7O, is a major nephritogenic antigen in ddY mice, a murine model of
spontaneous mesangial glomeru!onephritis associated with IgA and IgG
deposition. Immunofluorescence microscopy revealed that the mesan-
gial gp7O deposition increased with age in mice over 24 weeks old, as
did the EgG and IgA deposits. immunoelectron microscopy demon-
strated the reaction products of gp7O superimposed on the electron
dense deposits in the mesangial matrix. Various amounts of serum gp7O
were detected in mice as young as 12 weeks without any apparent
increase with age. There was no correlation between the serum level of
gp7O and the extent of the glomerular gp7O deposition, whereas mice
with heavier IgA deposition had higher mean levels of serum igA. The
absorption test demonstrated that significant amounts of serum gp7O
composed immune complexes in 40 week-old ddY mice developing
glomerulonephritis; however, this bound form of gp7O was not observed
in 12 week-old mice without glomerulonephritis. Systemic examina-
tions by immunofluorescence staining showed that gp7O was mainly
localized in various lymphoid tissues. These findings suggest that the
gp7O antigen, mostly derived from lymphoid cells, may circulate as
immune complexes and accumulate in the mesangial area, thus contrib-
uting to the development of glomerulonephritis in these mice. in
addition, the pathogenic role of the increased IgA production in these
mice was discussed.
lgA nephropathy has been described as one of the major
primary glomerulonephritis, characterized by the mesangial
deposition of igA, which is often associated with lgG and C3
deposition [1—4]. Although the pathogenesis of this disease is
still unclear, researchers have made various hypotheses regard-
ing the role of circulating IgA immune complexes [5—10].
Clinical data gathered to date suggest that factors such as upper
respiratory infections [11, 121, dietary antigens [13] and hered-
itary backgrounds [14-17] may contribute to the hypersecretion
of IgA, which is the major immunological hallmark of this
disease [18—21].
The experimental murine model of IgA nephropathy de-
scribed by Rifai et al, induced by the dinitrophenol(DNP)-IgA
anti-DNP antibody system demonstrated the pathogenesity of
the polymeric form of IgA [22]. Regarding the antigenic study,
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Isaacs, Miller and Lane have shown that immunization of a
polysaccharide antigen, dextran, in BALB/c mice can induce
the mesangial deposition of IgA antibodies [23]. Emancipator,
Gallo and Lamm demonstrated that oral immunization of pro-
tein antigens in mice elicited polymeric IgA response producing
mesangial IgA deposits, suggesting the pathogenic importance
of dietary antigens as well as the mucosal IgA antibody re-
sponse [24]. On the other hand, in a study using a mink model
affected with Aleutian disease, IgA was found to be the pre-
dominant deposit in the diseased glomeruli, and the pathogenic
role of viral antigen-antibody complexes was suggested [25, 26].
Recently, in search of a spontaneous murine model of IgA
nephropathy, tmai et at observed that the ddY mice developed
mesangial proliferative glomrulonephritis later in life, associ-
ated with prominent mesangial IgA deposition [271. On the
other hand, Chino, Sato and Sasaki have already reported that
retroviral infections are related to high incidences of malignant
tumors in these mice [28].
In this report, we studied the possible role of a retroviral
envelope glycoprotein, gp7O, in the pathogenesis of glomerulo-
nephritis in ddY mice. Previous researches have established
that gp7O is one of the major nephritogenic antigens in various
mice which develop lupus nephritis or necrotizing arteritis-
associated glomerulonephritis, all of which bear endogenous
murine leukemia virus (MuLV) infections [29—321. The results
of this study suggest that circulating gp7O-anti-gp7O immune
complexes may contribute to the development of mesangial
proliferative glomerulonephritis in these mice.
Methods
Mice
Female and male ddY mice which were maintained as a
closed colony, and BALB/c mice were purchased from Shi-
zuoka Agricultural Cooperative Association for Laboratory
Animals, Shizuoka, Japan and bred in our colony. The ddY
mice were bled and sacrificed at 12, 16, 24, 32, 40, 50 and 60
weeks-old. Only female mice were used in the present study.
Obtained blood samples were kept at —70°C until use.
Histological examinations
Tissue specimens from each organ were fixed in Dubosque-
Brazil solution for light microscopy, and the sections were
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stained with hematoxylin and eosin (H&E) and periodic acid-
Schiff (PAS). For immunofluorescence study, the tissue speci-
mens embedded in mounting media (Tissue Tek O.C.T. Com-
pound, Miles Laboratories, Inc., Naperville, Illinois, USA)
were quick-frozen using dry ice-acetone. Cryostat sections
were stained directly with FITC-conjugated antibodies against
mouse 1gM, IgG and IgA (Cappel Laboratories, Cochranville,
Pennsylvania, USA). The monospecificity of these antibodies
was confirmed by double immunodiffusion and immunoelectro-
phoresis. The detection of tissue gp7O was done using an
indirect fluorescence method with goat antiserum against gp69/
71 purified from Rauscher murine leukemia virus, provided by
Dr. John S. Cole III, National Cancer Institute, Bethesda,
Maryland, USA. The sections were subsequently incubated
with FITC-conjugated anti-goat IgG antibodies (Cappel Labo-
ratories). As a control, normal goat serum was used instead of
goat anti-gp70 antiserum. The specificity of the gp7O staining
was controlled by absorbing the goat anti-gp70 antiserum with
gp7O-rich concanavalin A fractions of sera from New Zealand
mice as described below.
Ultrastructural studies ofkidney specimens
Small blocks of the renal cortex were fixed in 2% glutaralde-
hyde and then in 1% osmic acid for electron microscopy. After
being embedded in Epon 812, ultrathin sections were treated
with uranyl acetate and lead citrate. In order to determine the
gp7O localization by immunoelectron microscopy, the cortex
specimens were fixed with periodate-lysine-paraformaldehyde
solution [33]. After being incubated in solutions of 10%, 15%
and 20% sucrose in phosphate-buffered saline (PBS), the spec-
imens were embedded in the mounting media, frozen, then cut
at 8 /.tm thickness. The IgG fractions of goat anti-gp70 antise-
rum were prepared with DEAE agarose gel coupled with
CibacrOn Blue dye (DEAE Affi-Gel Blue, Bio-Rad, Richmond,
California, USA), and labeled with biotin [34]. The sections
were reacted with biotin-labeled anti-gp7O antibodies and then
with horseradish peroxidase-avidin D complex solution (Vector
Laboratories, Inc., Burlingame, California, USA), followed by
fixation in 2% glutaraldehyde. The color was developed using
3,3'-diaminobenzidine as a substrate. The sections were post-
fixed in 1% osmic acid solution, and then embedded in Epon
812. Ultrathin sections were prepared for electron microscopic
observation. To distinguish the localization of the immuno-
reaction products from that of electron dense deposits, some
sections were poststained with uranyl acetate.
Preparation ofgp7O fraction
Pooled sera from New Zealand mice, obtained after lipopoly-
saccharide injection, which contain high gp7O activity [35],
were subjected to the column chromatography with concanav-
aIm A (ConA)-coupled agarose gel (ConA-Sepharose 4B, Phar-
macia Fine Chemicals, Uppsala, Sweden). The ConA-bound
glycoproteins were further purified using immunoaffinity aga-
rose gel column prepared with Tresyl-activated Sepharose 4B
(Pharmacia Fine Chemicals) coupled with an IgG fraction of
goat anti-Rauscher gp7O antiserum [36]. The purity of gp7O was
confirmed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis [36].
Measurement of serum gp7O activity
Serum gp7O levels were measured by inhibition radioimmu-
noassay [31]. A mixture of 50 l of 1:2.5 diluted serum samples
and 20 pi of diluted goat anti-Rauscher gp7O antiserum was
incubated at 4°C overnight. Then, 20 d of '251-labeled gp7O was
added to this mixture. After further incubation at 4°C overnight,
100 sl of diluted rabbit anti-goat IgG antiserum (MBL, Nagoya,
Japan) was added to each tube. The reaction mixture was
incubated for two hours at room temperature, and then for one
hour at 4°C. The resulting immunoprecipitates were washed by
centrifugation, and the radioactivity was measured using a
gamma counter. After the background correction, the results
were expressed in units, according to a standard curve obtained
with serially-diluted pooled sera from aged New Zealand Black
(NZB) mice. The gp7O content in the NZB sera diluted to 1:2.5
was tentatively defined as 100 units.
Measurements of serum immuno globulins
Serum concentrations of 1gM, IgG and IgA were measured by
solid-phase enzyme-linked immunosorbent assays [37]. Briefly,
microtiter plates were coated with goat IgG antibodies against
mouse 1gM, IgG or IgA antibodies (Cappel Laboratories). After
diluted serum samples were reacted with the plates, alkaline
phosphatase-labeled antibodies to each immunoglobulin class
(Cappel laboratories) were reacted to the bound proteins. The
results were expressed according to the standard curve ob-
tained by serially diluted immunoglobulins of each class.
Absorption test of serum gp7O activities
To determine whether gp7O binds to IgG or IgA antibodies in
sera, 0.5 ml of each of the two serum pools from 12 week-old
and 40 week-old ddY mice was passed through I ml of goat
anti-IgG or anti-IgA antibody-coupled agarose gel column pre-
pared with tresyl-activated Sepharose 4B (Pharmacia Fine
Chemicals). A bovine serum albumin (BSA)-coupled agarose
gel column was used as a control. After the sera were passed
through each of these columns, concentrations of IgG, IgA and
gp7O in the effluent fractions were measured as described
above. The percent ratio of each protein in the total effluent
fractions after absorption with each anti-immunoglobulin col-
umn to that after passing through the BSA column, was
calculated.
Statistical methods
Statistical comparisons were determined using Student's
f-test for unpaired data.
Results
Glomerular immunopathology
Diffuse mesangial cell proliferation was initially observed in
24 week-old mice which had increased PAS-positive materials
in the mesangial area, using a light microscope. These findings
were much more obvious in mice over 40 weeks old (Fig, IA).
Various degrees of mesangial deposition of gp7O, 1gM, IgG and
IgA were observed in mice over 16 weeks old by immunofluo-
rescence. Three out of 20 mice aged 50 to 60 weeks exhibited
crescentic glomerulonephritis with intensive mesangial deposi-
tion of these proteins (Fig. IB). The characteristic IgA deposi-
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Fig. I. A. Prominent PAS-positive deposits in the nesangial area oja glomerulus from a 60 week-old ddY mouse (PAS, x /570). B. A glomerulus
from another 60 week-old mouse. Global expansion of the mesangial area with hypercellularity and the crescent formation at the top of the
glomerulus (PAS, x 1360).
Fig. 2. A-C. Iminunofluorescence findings on the ,nesanguil gp7O deposition; A, B and C correspond to grade 1 (+), grade 2 (++) and grade 3
(f + +) deposition, respectively (X 1100). D. A characteristic grade 3 (+ + +) IgA deposition in the mesangial area in a 60 week-old mouse (x 1100).
tion and the various extents of gp7O deposition, graded from (+)
to (+++), are shown in Figure 2. Electron-dense deposits were
observed in the mesangial matrix of these mice using an
electron microscope as shown in Figure 3A. Immunoelectron
microscopic examinations revealed that at least part of these
electron-dense deposits were composed of gp7O. It was noted
that gp7O was not localized in the cytoplasm of the mesangial
cells, but rather, in the mesangial matrix (Fig. 3B).
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Fig. 3. A. An electronmicrograph from a 50 week-old mouse (x6700). Electron dense deposits are demonstrated in the mesangial matrix. B. An
immunoelectronmicrograph (x6700) poststained with uranyl acetate from the same mouse as in Fig. 3A. Distinct electron dense reaction products
of gp7O (thick arrow) can be seen in the mesangial matrix, with nonimmunoreactive electron-dense deposits (thin arrow).
Aging study on glomerular gp7O and immunoglobulins ages, from 16 to 60 weeks old (Table 1). At 16 weeks old, the
Deposits of glomerular gp7O, 1gM, IgG and IgA were corn- deposition of gp7O was negative or slightly positive (+). In mice
pared between groups, consisting of 10 mice each, at different over 24 weeks old, the positivity and intensity increased with
!S
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Table 1. Comparison of the grades of glomerular gp7O, 1gM, lgG and IgA deposition between groups, of 10 ddY mice each, at different ages
Age
weeks
gp7O 1gM IgG IgA
— + ++ +++ — + ++ +++ — ÷ ++ +++ — + ++ +++
16 4 6 0 0 0 7 3 0 3 7 0 0 0 10 0 0
24 1 6 3 0 0 3 5 2 0 7 3 0 0 9 I 0
32 2 7 I 0 0 2 6 2 0 6 3 1 0 6 4 0
40 2 3 3 2 0 4 5 I 0 7 2 1 0 5 5 0
50 0 4 4 2 0 I 5 4 0 0 4 6 0 6 3 I
60 0 5 3 2 0 3 4 3 0 2 4 4 0 2 5 3
Each figure indicates the number of mice exhibiting the corresponding grade of deposition out of a total of 10 mice in each age group.
8 40 12 24 32 40 60 (WI
BALB/c ddY
Fig. 4. The mean levels of serum gp7O in ddY ,nice, aged 12 to 60
weeks.
mice ar
For comparison,
e shown. The bar
the results with 8 and 40 week-old BALB/c
s indicate I SD from the mean values.
age. At 32 and 40 weeks, eight out often mice were positive. All
ofthe mice over 50 weeks old were positive, and more than 50%
of these mice tested moderately (++) or strongly (+++)
positive for gp7O deposition. 1gM deposition, however, did not
appear to be age related. All mice tested positive for 1gM
deposition, and more than 50% of mice over 24 weeks old
showed moderate or strong 1gM deposition. On the other hand,
the deposition of IgG and IgA tended to increase with aging. In
16 week-old mice, both deposits were negative or slightly
positive. Deposits were found to be grade (+ +) or greater in
mice over 24 weeks old. In mice over 40 weeks old, these
moderate or strong deposits were observed in higher frequen-
cies.
Serum gp7O levels
Results of the tests on control BALB/c mice showed that
serum gp7O levels were low in both 8 and 40 week-old mice,
with mean so of 4.3 2.0 units and 4.3 1.5 units,
respectively. On the other hand, in ddY mice, gp7O levels
varied widely, showing great individual differences at every age
tested. There was no apparent age-associated increase of the
mean levels. The mean SD values at 12, 24, 32, 40 and 60
weeks were 19,9 16.3, 37.4 28.3, 28.4 25.5, 47.0 41.2
and 19.5 18.4 units, respectively (Fig. 4).
Relationship between glomerular gp7O and the
immuno globulins
Fifty mice, aged 24 to 60 weeks old, were analyzed to
determine the relationship between the degree of gp7O deposi-
tion and those of the immunoglobulins in glomeruli. When the
mean scores of 1gM, IgG and IgA depositions were compared
between groups of mice with different grades (—, +, + +, and
+ + +) of gp7O deposition, it was found that each of these
immunoglobulin deposits tended to increase as the grades of the
gp7O deposits increased (Fig. 5). This was particularly obvious
with IgA deposits: The mean scores of IgA deposition in mice
with (—), (+), (+ +) and (+ + +) gp7O deposition were 1.0, 1.2,
1.8 and 2.3, respectively.
Comparison between serum levels and glomerular deposits
The serum levels of gp7O and each immunoglobulin were
compared between two groups of mice, with weak (—or +) and
strong (+ + or + + +) glomerular deposition of the correspond-
ing proteins (Fig. 6). There were no significant differences in the
mean serum levels of gp7O and IgG between the two groups.
High serum 1gM levels were observed in mice with strong 1gM
deposition, although this was not statistically significant, Mice
with weak IgA deposition generally showed low serum IgA
levels with a mean SD of 54.3 27.5 mgldl, while mice with
strong IgA deposition tended to show high serum IgA levels
with a mean SD of 137.1 57.0 mg/mI, with the difference
between the two groups being significant (P < 0.001).
Absorption of serum gp7O with anti-immunoglobulin columns
Pooled serum samples from 12 and 40 week-old ddY mice
were absorbed with anti-mouse IgG and anti-mouse IgA col-
umns. After absorption, the gp7O activities were compared with
those of effluent fractions from a control BSA-coupled column
(Table 2). The pooled serum from the 12 week-old mice did not
show any significant reduction in gp7O activity after absorption
with either column. On the other hand, the gp7O activity of the
pooled serum from the 40 week-old mice was noticeably re-
duced after absorption with either column. That is, with the
anti-IgG column, the gp7O activity was reduced to 57.9%,while
with the anti-IgA column, the activity reduced to 59.5%,
compared with that of the BSA-column effluents.
Tissue distribution of gp7O
In the immunofluorescence studies, gp7O was detected in
frozen sections of various organs from two BALB/c (2 months-
old) and each of five ddY mice, aged 12 and 60 weeks (Fig. 7).
In the BALB/c mice, gp7O was faintly positive in the bronchial
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epithelial cells, some renal tubular cells and the acinar and
ductal epithelial cells of the salivary gland. In the other organs
including lymphoid tissues, liver, heart and intestine, gp7O was
not detected. In 12 week-old ddY mice, faint staining in the
epithelial cells was also observed as in the BALB/c mice. In
addition, various grades of positive findings from faint to
moderate, were obtained in the thymus, the spleen, cervical and
axillary lymph nodes and Peyer's patches. Of these lymphoid
tissues, cytoplasmic staining was observed in scattered cells in
the periarterial region of the spleen and in clustered cells in the
germinal centers of the spleen and various lymph nodes.
Especially in Peyer's patches, almost all cells of the germinal
center displayed positive staining. It was noted that some small
round cells in the lamina propria of the intestinal mucosa were
brightly stained in the ddY mice. In 60 week-old ddY mice, the
intensity of these lymphoid cytoplasmic stainings was greater,
while the epithelial cells remained faintly or weakly stained.
Furthermore, the infiltrated leukemic cells in these older mice
were also brightly stained.
Discussion
This study was performed to examine the pathogenic role of
gp7O, a retroviral envelope glycoprotein, in the development of
glomerulonephritis in ddY mice. The results show that gp7O
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Table 2. Results of the absorption test: Serum gp7O activities with
BSA, anti-lgG and anti-IgA columns
Concentration in effluent fractions after
Age
weeks
absorption
Absorbed with lgG pg/m! IgA /2g/ml gp7O units
12 BSA column 121.1 7.8 52.8
Anti-lgG 5•7 (4•7)a 10.6 (135.8) 50.0 (94.7)
column
Anti-IgA 116.9 (96.5) 0.7 (8.9) 52.3 (99.5)
column
40 BSA column 256.4 8.4 94.1
Anti-IgG 13.0 (5.1) 10.5 (l25.0) 54.5 (57.9)
column
Anti-IgA 207.1 (80.8) 1.0 (11.9) 56.0 (59.5)
column
In parentheses: The percentage value relative to the BSA-column
effluent value
accumulates in glomeruli at least partly forming circulating
immune complexes.
The development of mesangial proliferative glomerulonephri-
tis associated with mesangial IgA deposition in ddY mice over
40 weeks old, was first described by Imal Ct al [271. Although
the renal findings in this study were similar to those described
by them, the conspicuous IgG deposition as well as IgA
deposition was noted with aging. In addition, we observed a
variety of cases, with mild to severe glomerular lesions even
forming crescents, which mimic human IgA nephropathy. Re-
garding tumor formation, malignant lymphoma or leukemic cell
infiltration in the various organs was observed in four mice over
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Fig. 6. Comparison between the serum levels and the grades of gb-
inerular deposition of gp7O(A), IgM(B), JgG(C) and IgA(D) in 22 ddY
mice, aged 24 to 40 weeks.
(—I H-) (++)
gp7O Deposits
(—)—(+) (++)—(++i-) (—)—(+) (++)—(+++)
(+ + +1
Fig. 5. Comparison of the grades of gbomerular 1gM, IgG and IgA
deposition in relation to the extent of gp7O deposition. The bars indicate
the means 1 SD.
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Fig. 7. Immunofluorescence gp7O staining in the spleen (A), the thymus (B), Pcyer'spatch (C) and the lung (D) in 60 week-old ddY mice (x264).
A. Cells in the germinal center and the periarterial region are positive. B. Both clustered and scattered cells in the thymic medulla are stained. C.
Strongly positive findings are shown in almost all of the germinal center cells. D. Conspicuous staining of the infiltrating leukemic cells in the lung.
24 weeks old, out of the total sample of 50 female mice under 60
weeks old, although such tumor formation was not described by
the former group. Chino, Sato and Sasaki (28] described the
increasing incidences of malignant lymphoma in aging ddY
mice. They reported the incidence rates of 2.6, 6.9 and 17.2% in
mice aged approximately 60, 80 and 100 weeks, respectively.
Notably, they identified C-type retroviral particles in the ma-
lignant lymphoma in these mice. These results suggest that the
gp7O antigen may be one of the causative factors in the
development of the glomerulonephritis in these mice.
Immunofluorescence testing on tissue localization of gp7O in
ddY mice yielded positive findings in various lymphoid tissues
such as the spleen, the thymus, cervical and axillary lymph
nodes and Peyer's patches, with less intensive distributions in
various epithelial cells, as was demonstrated in autoimmune
New Zealand mice [38]. Although malignant lymphoma or
leukemia was observed in only a small fraction of these mice,
the positive gp7O findings in the lymphoid cells of all of the ddY
mice tested, suggest that the fairly selective expression of an
endogenous MuLV genome (gp7O) in lymphoid cells may be a
common feature of these mice, This characteristic lymphoid
distribution of gp7O in mice, aged 12 weeks, with individually
different degrees, seem coincident with the early appearance of
the wide range of serum gp7O activities. These findings suggest
that most of the serum gp7O activities may have been derived
from these lymphoid cells in ddY mice.
With regard to the mechanisms of the localization of gp7O in
the glomeruli, it seems unlikely that gp7O binds to glomerular
mesangium as a free molecule having high affinity for the
mesangial tissue, since the serum gplO levels did not correlate
with the amounts of glomerular gp7O. It is possible that gp7O
may be produced by mesangial cells; however this is also
unlikely, because the immunoelectron microscopic examination
revealed that gp7O was localized only in the mesangial matrix,
and not in the cytoplasm of the mesangial cells. Rather, it seems
likely that gp7O circulate as immune complexes which accumu-
late in the mesangial area. Findings that there is a relationship
between the extent of gp7O deposition and that of the IgG and
IgA depositions, and that no mice showed gp7O alone in the
glomeruli without any immunoglobulin deposition, support the
hypothesis mentioned above. The further evidence of the
presence of gp7O immune complexes in the sera of mice with
glomerulonephritis was obtained using the absorption test with
anti-IgG and anti-lgA antibody-coupled affinity column chro-
matography. Significant absorption rates (approximately 40%
with each column) of the gp7O activities were demonstrated
with sera of 40 week-old mice which developed characteristic
glomerulonephritis. In contrast, almost negligible absorption of
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gp70 activities was observed with sera from 12 week-old mice
which did not develop the glomerulonephritis. These findings
suggest that significant numbers of gp7O molecules circulate as
nephritogenic immune complexes in these mice. However, the
result of the present absorption study may not directly disclose
the presence of gp7O-IgA immune complexes nor gp7O-IgG
immune complexes, because there may be interactions between
IgG and IgA antibodies in sera from aged mice developing
glomerulonephritis [39].
Recent research indicates that the electric charge is one of the
crucial factors in the localization of circulating immune com-
plexes in glomeruli because of the negative charge of the
glomerular basement membrane [40, 4!]. It has also been
reported that the anionic immune complexes tend to accumu-
late in the mesangial area, whereas the cationic immune com-
plexes tend to localize in the peripheral capillary walls [42, 43].
Assuming that gp7O is an anionic molecule having a p1 of 4.6
[44], and that serum IgA antibodies are anionic [45] and the
most of serum IgG antibodies are neutral or cationic in electric
charge, it seems likely that the totally anionic nature of gp7O
immune complexes may give favor for the mesangial localiza-
tion of these immune complexes, as was observed in this study.
From the viewpoint of the mechanisms of glomerular IgA
deposition of these mice, the role of polyclonal B cell activation
should be considered, because there was a significant relation-
ship between serum levels of IgA antibodies and the extent of
the glomerular IgA deposition, suggesting the direct accumula-
tion of the polyclonally increased IgA in the mesangium. In this
context, our preliminary analysis of the qualitative aspects of
IgA has shown that IgA in the sera of mature ddY mice were
found to be both multimeric and polyclonal (unpublished ob-
servation).
Of the various animal models of IgA glomerulonephritis
described so far, the ddY mice model is unique because of the
spontaneous age-related mesangial IgA and IgG deposition in
the background of retroviral infection. Studying this model
would help us elucidate the pathogenic role of circulating
immune complexes made of the known viral antigen (gp7O), and
also the fundamental mechanisms of the hyperproduction of
IgA antibodies.
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